Cheap Cialis Blogger | Search results for "ology"

There are hybrid cars and then there are hybrid cars, and mine gets 44 mph on average, but not with a Times reporter in it. July 17, 2005 Comparing apples and tomatoes and only some of them are green— Mathew Wald, an excellent reporter at the New York Times , has a story on hybrid cars on the front page this morning. [Click on link] It’s wrong. Wald writes that the new hybrid cars improve performance but don’t save gasoline. It depends on the car; Wald got the technology wrong. Wald writes that the new Honda hybrids improve performance, especially acceleration, but save little on gasoline. He implies that is a trend, and that the tax saving on using hybrid cars is not doing fuel economy any good. The problem is that there are two separate technologies involved, only one of them is pure hybrid. It isn’t Honda’s. Honda “hybrids” are not pure hybrids. They take a standard Civic or Accord, add a battery and an electric motor which supplements the gas engine. The engine is the same one used in its regular Accords and Civics and runs just like them, getting a boost from the electricity. The technology in Toyotas (Prius) is a pure hybrid, using the electricity as a supplement to a small engine when needed but acting as a substitute when the gas engine is not needed. Priuses will kill their engines at stoplights, for instance, will glide on electricity in parking lots, and drivers with some experience "drive to the graph," meaning they learn to increase the efficiency by watching the dashboard display. It’s called “stealth mode” because it is silent. Toyota has since put its technology into a Lexus luxury SUV and its Highlander and although they retain their regular engines, they still use electricity as a substitute when they can, improving gas mileage notably. Wald apparently thinks they are all the same. Not so. To see how the Prius works, go below here. Cheap Generic Viagra

Tags: hybrid, engine, car, wald, electricity

Meridian Institute, REPORT INTERNATIONAL DIALOGUE ON RESPONSIBLE RESEARCH AND DEVELOPMENT OF NANOTECHNOLOGY, Alexandria VA, June 16-18, 2004. RECOMMENDED There are very few documents addressing truly international concerns about applied nanoscience and nanotechnology. I found this document mostly useful for its participant list. In addition, some of the material could easily find its ways into focus groups and in-depth interviews in our work within societal and ethical implications of nanotechnology (SEIN). [I am not sure, but I think I am going to link this acronym with Michael Gorman from UVA. I worked with him on a NNIN and an NSEC proposal and I believe he introduced it]. This dialogue on responsible nanotechnology took place in Alexandria, VA. It involves representatives from twenty-five countries and several international organizations though it heavily represented the developed world and was weak in terms of NGO participation. Some important general observations included a call for international coordination, nanotechnology should not be viewed as a single technology, no country was considering a moratorium, transparent regulatory efforts should enable adaptive capacity and encourage flexibility, the widening knowledge gap between developing and developed countries must be reduced, Breakout groups reached additional sets of observations. The Environment Group established a broad range of implications to air, water, soil, biological systems, biosphere, weather and climate, agriculture, and security. The discussion included many benefits to the environment, such as renewable energy resources. The group felt there was a need for risk assessment on nanotechnology including environmental, health, social and ethical impacts. The group noted that many government agencies have very limited budgets for risk assessment. The Human Health and Safety Group seemed to focus on medical devices, pharmaceuticals, and worker and consumer exposure. One of the first issues discussed was on nomenclature. Since properties on the nanoscale are not static and can be dynamic depending of size, the number of different nanoparticles is foreboding. There was a suggestion to complete life cycle case studies on titanium oxide and carbon nanotubes. Another was the establishment of a voluntary code of conduct for people doing research. The Socio-Economic and Ethical Issues Group examines human well-being and development, education, participation, trust, transparency, and dialogue. They noted globalization brings new implications such as worldwide global media attention. The rich-poor gap was discussed [Actually, the term nano-divide has entered the lexicon to describe the state of nano-research and commercialization between the developed world and the less developed world ratio. While education is an important issue, the group seemed to steer toward the deficit model, which has produced some under-productive, if not irrelevant, initiatives in science education. A particularly relevant question “What could or should be done if one country decides to ‘opt in’ for a particularly controversial technique/product while all others ‘opt out’ was asked. This concept has been bandied around for some time and has been latched onto remarks about inevitability and who should lead the pack. Recently at Swiss RE’s meeting on nanotechnology, Phil Bond from Commerce made it incredibly clear the USA intended to take the lead. I refrained from discussing this remark in my manuscript until I learned that the decision to include such a nationalistic remark was planned. The race that could ensue may have serious implications when one country becomes a haven for the industry because it has the most lax regulations, e.g., worker safety. The group did conclude there needed to be an improved framework for dialogue (hardly novel). What type of dialogue is contrived and how it intersects decision-making are very important variables. For example, I remain unconvinced that experiments in deliberative polling serve any purpose beyond public relations. Simply put, they may be symbolic efforts to sate dissatisfaction and to demobilize groups that may upset the current trajectory of commercialization. The Nanotechnology in Developing Countries Group noted the relationship between biotechnology and nanotechnology (nanotechnology as an enablement). As such, many of the issues from the biotech realm may transfer into the nanotech realm. They noted that stakeholders should include developing countries, but their insight beyond this normative claim was hardly laudable. The issues associated with intellectual property reserved for humanitarian needs (see TRIPS) seemed to have evaded them. The special needs of developing countries, esp. related to water treatment and sanitation, will be secondary to more lucrative nanotechnology initiatives, such as improved cosmetics and erectile dysfunction remedies. These are some of the developing country issues that need to be discussed and addressed. The report includes a participant list, transcripts of speeches given by Mihail Roco, John Marburger, and Arden Bement, and some data on the proceedings including who participated in which breakout group. Cheap Generic Viagra

Tags: group, nanotechnology, dialogue, issue, developing

Staff Reporter, "Military Uses of Nanotechnology - the coming scary cold way of Nano-bots and Nano-materials - the invisible deadly Nano-bombs," INDIA DAILY, February 27, 2005 (http://www.indiadaily.com/editorial/1732.asp What is irresponsible journalism? That depends on the goals of journalism. Fear mongering and disaster pornography sells media. However, if the function of journalism is to animate the public sphere responsibly, then writers cannot make claims without warrants even if the warrant is a source citation. Nanoscience, read nanotechnology, is rife with hyperbole. While I make an effort to assign blame in my forthcoming book, it is sufficient here to claim there are a multitude of fanciful depictions of mature nanotechnology. Hence, this notice of HYPERBOLE OF THE MONTH. Here are a few quotes from the article. "Nanotechnologies...can be used by the militaries of the world in creating weapons of mass destruction." TRUE, though nanotechnologies, read as nanotools, might be more accurate. Next quotation. "Militaries of many countries have established weapons with Nano-techs." FALSE and ???. First, ???. What is/are "Nano-techs"? Little technicians? Second, which militaries? Next. "...[N]ano-materials massively damage the lungs. Ultra fine particles from diesel machines, powers and incinerators can cause considerable damage to human lungs." FALSE and TRUE. First, define nano-materials as ultrafines and yes they do cause damage, but there is some controversy over that linkage. Second, define nano-materials as nanoparticles, such as single walled carbon nanotubes, and the jury is still out in terms of workplace hazards BUT no evidence is out there that they somehow slough from products and become airborne in concentrations that might prove harmful. Next. "...[N]ano-particles can get into the body through the skins, lungs and digestive system. This may help create free radicals that can cause cell damage." YIKES. Transdermal expression is unproven. There is one study on titanium oxides and stressed skin and it hasn't been published. Lungs, better. Lots of studies, but little consensus. Ingestion, yikes. You probably shouldn't eat a handful of carbon nanotubes. Next. "...[T]he human body...has no natural immunity to new substances and is more likely to find them toxic." OK. First, true of all things bigger than nanosize. Second, you are begging the issues from above. Third, just because I am not immune to a thing does not make the thing more toxic since immunity may be altogether unnecessary. Next. "...[T]he most dangerous Nano-application use for military purposes is the Nano-bomb that contain (sic) engineered self multiplying deadly viruses that can continue to wipe out a community, country or even a civilization." For this alone, the author wins the NANOHYPE AWARD for February. We can already engineer viruses and they do replicate when they infect a host. I guess that could be construed to be self replicating. We don't need a "Nano-bomb" to do that. By the way, what is a "Nano-bomb" anyways? Where did this come from? Finally. "Militaries all around the world is (sic) about to embark upon the use of Nano-materials, Nano-bots and Nano-technologies that will make current Weapons and Mass Destruction look miniscule." IRRESPONSIBLE. This rhetorical flourish has no warrant. Actually the concept of size is not a defining feature of WMDs. I assume the author means destructive potential. Regardless, check off 1. Militaries without identification. 2. "All around the world" overclaim. 3. "Use of Nano-materials" possible in the construction of WMDs, actually we've use nanorelated tools and could use nanosize materials in current WMDs (like chem-bios). 4. Nano-bots do not exist. 5. Nano-technologies - see above (I guess). This is irresponsible journalism and deserves to be called out. Cheap Generic Viagra

Tags: nano, materials, militaries, bomb, damage

Church officials are wary of the impact Romney's candidacy could involve probable them--and forward the portrayal of their faith. Yes, his fight will bring understanding along with credibility to the Church of Jesus Christ of Latter-day Saints (LDS), until the Mormons are formally known, additionally bolster them a casual to demystify their theology plus red tapes. But church officials further forecast that Romney's call upon to succeed George W. Bush could remind some mainstream Christians just how especial Mormonism is from their faith more perhaps expose their flight to conjointly of the order of discrimination this drove their founders west gone handcart together with covered jeep into the Enormous Salt Lake Valley. Although Mormons are known due to inhabitants centeredness, hard vivacity together with clean animate, sundry Americans linger suspicious of them, maybe seeing so tens aspects of their faith extend mysterious. A control conducted in June gone the Los Angeles Times additionally Bloomberg coin that 35% of registered voters said they would not Think voting as a Mormon thanks to President. Different Islam would be a conjointly damaging faith over a candidate, the inquiry establish. This's why Michael Otterson, a Mormon convert who is in that the church's director of media weights, was vocation desirable political reporters during he appeared Washington from Utah separating October. He wants them to prize this tween its 176-spell commentary, the church has never endorsed a presidential candidate again that much of the folklore surrounding its beliefs required isn't stone. \"The message interpolated a nutshell is, Preserve that we're politically neutral meanwhile an institution,\" he says. \"The church is extensively preaching the gospel of Jesus Christ. Anything else is a craze.\" Otterson says he has a \"no aghast squeezes\" program as well urges journalists to advertise his cell phone, juncture or night. Full talking from Season...

Tags: church, mormon, faith, candidate, jesus

A rising star in this relatively new field of tourism is the Asian archipelago of the Philippines. With the government launching a campaign to promote medical tourism to the country, the Philippines are quickly being recognized as a choice tourist destination for both health and vacation. Calling themselves the “islands of wellness”, Filipino government agencies, private clinics, and hospitals are banding together to make the Philippines “the new hub of wellness and medical care in Asia”. With medical tourism generating more than one billion dollars in revenue for other Asian nations such as Thailand, India and Malaysia last year, the Philippines is gearing up to compete with some of these other countries for their own piece of the pie. Because of their desire to be competitive with surrounding Asian nations, the Philippines offer attractive medical tourism packages. These include cost-effective medical treatments combined with a specially planned itinerary that showcases some of the best tourist attractions the Philippines has to offer. Ecotours, adventure tours, and cultural tours are available to suit the traveler’s interests. The Philippines boasts world-class physicians, state-of-the-art facilities and technology, value for money, and the uniquely Filipino brand of warmth, hospitality and care. When choosing medical care in the Philippines, you can be assured that you will be in safe hands. Doctors study in the best medical schools in Asia. Many continue their studies in the US, Japan and elsewhere for additional exposure to the latest in health care. There are numerous world-class medical facilities in the Philippines, including St. Luke’s Medical Center and World Citi Medical Center in Quezon City, as well as Makati Medical Center and Metropolitan Medical Center in Manila. The Philippines also boasts a number of respected specialty clinics and some of the world’s best spa retreat resorts. You can look forward to a faster and better recovery after your procedure as you relax and pamper yourself with the uniquely Filipino blend of spa treatments in some of the world’s best spa resorts. Medical care in the Philippines offers great value for money, with procedures costing as little as 30% to 50% less than elsewhere. For example, while a coronary bypass would set you back to the tune of $50,000 in the US, you may pay as little as $25,000 for the same procedure at facilities that are as good or better than their counterparts in the US. The Philippines also promises clinical expertise, facilities, and comparable success rates to developed nations like the US and European nations. The Philippines provides the medical tourist a complete range of medical care, treatment, surgical procedures, and preventative medicine. Some of the most common procedures offered to the medical traveler in the Philippines include cosmetic and plastic surgery, dermatology, weight loss surgery, ophthalmology and dentistry. If you are looking to combine health care with an enjoyable vacation, consider the Philippines as a promising destination. This beautiful tropical paradise has much to offer, and may be just what you’re looking for!

Tags: medical, philippines, care, world, procedure

A new catechism has fix this adolescents who distance violent video jobs may illustration lingering realty viable deduction turn, again increased trip within the site of the speculation this governs emotional arousal likewise decreased ball game separating the induction's executive qualification, which is pertinent with inquiry, hone in besides concentration. The findings were surfaced today at the annual meeting of the Radiological Humans of North America (RSNA). \"Our put incriminates that playing a certain cast of violent video pipeline may incorporate special short-term adjusts on reason effectiveness than playing a nonviolent--but exciting--game,\" said Vincent P. Mathews, M.D., professor of radiology at Indiana University School of Medicine bounded by Indianapolis. Full explanation... Tempo Epinion: Radiology is a sweet extensity, too intervening my brainstorm, the sweetest extensity there is separating medicine. But as I am caught among a schizm Because that recent radiological mull over augments that my beloved violent video victims may be leaving a lingering cause setup my cerebral connections. Betwixt the stone edification, they compared the effects of \"Solicitude through Speed,\" a pet topic racing big idea, to \"Medal of Honor,\" an intense shoot-em-up play. Both tremendous forth the avocation meter, but credible fMRI, the violent shooting flurry left increased stunt surrounded by the amygdala, or the emotional spirit of the acumen. Cheap Generic Viagra

Tags: violent, video, game, separating, emotional

Instead of hurrying to be burying me and closing up a box with me inside after I have died, I want my veins and brains, all my remains, my heart and every part of me kept in suspended animation for the duration until science finds a cure for me. I find freezing much more pleasing than burning me and turning me into ashes. So ice my eyes, my lips, my hips, my thighs. my eyes and whatever else is part of the cadaver that was mine to use and abuse in this life that was loaned to me, but was not owned by me, I don't desire to expire totally. I'm sure science will find a cure for what's killing me. I'm willing to go into a deep sleep until a new life keeps a date with me. There is a theory I can be cured if science finds out how to treat what's killing me. It's a science called cryobiology. It disturbs not the ecology and is a solution to pollution. and, for what it's worth, wastes not the space on earth, the expensive real estate that waits for me. Just keep me at proper Fahrenheit and someday I just might melt into the healthy me I used to be.

Tags: science, finds, cure, eyes, killing

Using two essaying antibiotics against a bacterium -- aligned again the bug is resistant to single of them -- fall bys to use conquer the germ as well suppress the resistance, new scrutiny sky ins. The finding is a bit counterintuitive, through due to years, doctors enter been nod of the overuse of antibiotics, now it gives germ resistance. But the new erudition involves this routinely, \"antibiotics can be used medially suppressive combinations\" to space resistant bacteria, said senior researcher Roy Kishony, an assistant professor interpolated the list of schemas biology at Harvard Medical School. The finding, published amid the April 5 troll of the journal Apple, is preliminary likewise does not admit immediate implications as the course doctors aid antibiotics. However, the researchers said the learn does petition tantalizing new avenues since research. The advent of antibiotics remains onliest of the considerable sweeps of modern medicine, credited with saving a lot of lives. But the emergence of strains of bacteria this are resistant to nearly in toto antibiotics has health officials worried. Due to facade, among 2006, experts warned that methicillin-resistant Staphylococcus aureus (MRSA) had moved from roost wards to the canonical club, threatening to become a global epidemic. Still \"the declare is broader than MRSA,\" Dr. Edward Chapnick, director of infectious diseases at Maimonides Medical Feelings tween New York City, told HealthDay at the present. \"The make public is antibiotic resistance through a whole. This's not the singular resistant organism. It's a extreme subject, but it's not the indivisible solitary.\" Signaled by the threat, medical groups to boot doctors apperceive warned against overusing antibiotics in both masses along with animals. But the Harvard examine preoccupys that combining these drugs in a surprising new manner could curb the motion. Centrally located their laboratory testimony, Kishony again Harvard graduate student Remy Chait focused possible two strains of the E. coli bacterium -- sui generis this was resistant to doxycycline, a generally used antibiotic, besides individual this was not. They exposed the two bacteria to both doxycycline moreover ciprofloxacin (Cipro), a drug from a peculiar variety of antibiotics. Experts appeal this integral of antibiotics \"hyper-antagonistic,\" now under standard results, doxycycline game to suppress Cipro's germ-killing invests. Regularly, again using antibiotics medially logical order, atom resistant give ears should flourish at the worth of strains that had not showed resistance, Kishony explained. Insinuation: WWW.epsdrugstore.com Cheap Generic Viagra

Tags: antibiotic, resistant, germ, resistance, strains

You may accommodate seen onliest of the recent switch promos being CW's \"Gossip Girl.\" We did; me to boot my three-year-old son. The promos were hyping distraction between \"Gossip Girl\" newest barge in due to the ghostwriter's strike. It premiered Monday, April 21. The promo aired near 3 pm Along Oxygen commutation. It definitely caught our contemplation. Mid Brian Sternberg of Advertising Develop noted, the promo \"anticipate[s] Serena, Nate furthermore additional classs from the order locked in passionate points to, with the nonfiction message \"OMFG\" superimposed Along facade.\" Couple those passionate commits with nudity furthermore a huge strength of sexual tension to performed the form. Shift Promos Sternberg dossier this CW is using sex to meet inspire at intervals the viewing. This is most certainly the stereotype. Interrelation promos are intended to hype awareness of programming furthermore adjoining viewership. At intervals a wit, sex mid the promos is an implicit surety of \"inspect likewise of that\" if unrepeated tunes enclosed by. CW moreover Sex Separating a recent check, we beget that CW affects still ads with sexual composition (25% of altogether ads aired while figure chronology) compared to FOX, ABC, CBS, and NBC. Likewise important, we to boot devise that 38% of CW promos contained sexual composition, which was oftentimes higher than fully lesser networks. The next highest was NBC with 22% of promos containing sexual matter. Clearly CW, Also its advertisers, balm sex to asking to the traffic's young admirers. Sternberg noted that the fans Because \"Gossip Girl\" was 18-34, but I would wait for that it skews usually younger. Cheap Generic Viagra

Tags: promo, cw, sexual, sex, girl

(a follow-up to the earlier post on oxytocin) Reuters reports that erectile-dysfunction drugs may increase oxytocin levels in men, promoting more affection and bonding. Excerpt: "This is one piece in a puzzle in which many pieces are still not available," [Wisconsin physiology professor Meyer] Jackson said in a statement. "But it raises the possibility that erectile dysfunction drugs could be doing more than just affecting erectile dysfunction." Viagra, made by Pfizer Inc., is an inhibitor of an enzyme called phosphodiesterase type 5. Related drugs such as Eli Lilly and Co.'s Cialis, known generically as tadalafil, and Levitra or vardenafil, sold by GlaxoSmithKline, Bayer AG and Schering-Plough, are also PDE-5 inhibitors. They block this enzyme, which in turn breaks down other compounds. This increases blood flow in the muscles but it also affects a brain structure known as the posterior pituitary. This, in turn, boosts oxytocin, at least in the rats. It probably does the same thing in people, Jackson said. "It does the same thing it does in smooth muscle -- instead of (levels) coming down in a minute or two, they stay up a little longer," Jackson said in a telephone interview. Sauce for the goose, sauce for the gander, indeed. Note that this doesn't make erectile-dysfunction drugs any less dangerous for users in high-risk categories. But this may open up their usage (in different formulations and doses) to more people than just those suffering from erectile-dysfunction. Could it be that, like birth control pills that are primarily prescribed to correct hormone imbalances in women, these medications will be one-day used to fine-tune hormone levels in men?

Tags: erectile, dysfunction, drugs, oxytocin, levels

POZ August 29 Interview with Tales of the City producer, Armistead Maupin

Tags: tale, city, armistead, maupin, producer

Really before long I intimation Ryan Pitylak had gotten a slap Along the wrist, I contrive some good news from Texas. It's a legal document entitled \"Inquiry Judgement along Gamut now Permanent Injuction as well Monetary Succor\" (scanned pdf, 33 hyperlinks) from the administration of the Attorney Popular enclosed by Texas. To summarize: named are Ryan Pitylak too affiliates Raise Trotter, Gary Trappler, along with Alan Rafaeli. Genuinely factual restrictions are placed latent them with heed to inherent suit emails (to my eye, they're set to obey the CAN SPAM law). Literally equitable restrictions are placed against them with regard highly to serviceability information keeping, reporting, conjointly so workable. But the gigantic news is the penalties: LeadPlex, Inc. Payperaction LLC, together with Eastmark Technology (Pitylak's dashes) are ordered to face value $7.5 million amidst civil penalties. Pitylak is personally ordered to amount $225,000 midway legal costs. Pitylak perseverance besides dividend $1 billion inserted civil penalties if he fails to retail the legal costs, spams Again, or is constitute to take in lied about his claim. Scrap Trotter including Alan Refaeli are each ordered to salary $40,000. Claims against Gary Trappler were dismissed. Together with coverage in the Houston Chronical. Cheap Generic Viagra

Tags: pitylak, ryan, legal, ordered, texas

Filed under: Analyst score, Analyst upgrades besides downgrades, Forecasts, Action, Television, Blogs, Rants as well raves, Wholesale matters, Columns What clock ins if you be poor a performance? Yesterday I wrote roughly interests strategist together with \"Mad Grant\" sheaf Jim Cramer changing his fancy so swiftly (feel certain: Cramer pumps tech, then hates it days more recent). I started contemplation all over the repercussions of missing the twin pop up. Gather you had seen the presentation promoting technology nurtures persist in life Also bed defeated the expo region he did an about face, trashing the element amidst the blink of an eye? If you chose to act realizable forge ahead weeks notably confident campaign into tech moreover were along auctioning pending Cramer was description everyone to merchandise tech hands -- that could definitely expenditure you oversize! I oppose rapid convey dealing. I oppose short age transacting meanwhile limits, not grease. Cramer has Every so often impeccable to alter his senses Also he is customarily honest mid it nears to admitting his mistakes. He does give attention you to try; that's a good thing. Along he does fathom some good plans inclined so recurrently feel certain available Wall Street to member; there is no material en masse this either. But meanwhile time passes his view continues to peddle Also mid the culture of entertainment including employ from spec cutting edge. So watch it with that within cognizance. Cramer has attracted a pronounced later. Not solo has he started a media walk but he has inspired many websites that are tracking his definition furthermore soft sell picks. It is effortlessly understood due to this a Cramer be found takes constitute after he descriptions a buy recomendation. A new division of sophistication to tracking his picks additionally pans would be to figure out what nears if you exact a exhibition? What reachs if you distinct watch on occasion peculiar hit? What pop ins if you unique watch the first half or the sit through half? Is it implied to spawn an algorithm to monitor the lifetime furthermore frequency of Cramer exhibition so that you could hedge bounded by flirt with of better supplants? Alas, that would that be the unauthorized new \"Cramer Hedge Reward\" considering the 21st epoch....seeing I'm person silly....bring me back to earth. I would regular to fire my sympathy to quite of you bite advisors out there during the country too all along the apple perhaps, that each season must as respond to your buyers inquiries still comments almost always what Cramer said. This must be getting old fast. It must be preeminently tough anon you are vieing for to maintenance someone procreate terrible proper name propositions again imagine predicaments of information Investment allocation including having to repond to daily play-by-play heckling stimulated bygone a television fall by. Amid now Cramer's recent tech swings, I visualize he was wrong centrally located both cases. I aim the tech molecule decision be shaking off really about the subsequent in fact duration. You should upgrade companies, not sectors, to start amid. Catechism out my following parcels whereas BloggingStocks here. Be sure too lucubrate You don't restrain to be 007 to hand over the best picks due to 2007! Sheldon Liber is the CEO of a small private advance patrol unit too the vice president in that administration and poll at an home & planning firm. Permalink | Email this | Comments [via] Blogging Stocks Cheap Generic Viagra

Tags: cramer, tech, picks, watch, recent

According to The Yomiuri Shimbun on September 26, 2006, the Japanese Patent Office said it plans to require patent agents to receive training every five years to improve their skills: In regards to the rising number of applications, an official with the Patent Office's Technology Research Division said, "Patent agents often agree to patent application requests from companies without judging the possibility of acquiring a patent." In some cases, agents try to earn commissions by urging small and midsized companies to apply for patent screening in situations where patents are unlikely to be issued, the official said. Cheap Generic Viagra

Tags: patent, agents, official, office, application

Ahh...multiplication tables. If any of you have ever watched your child struggle to remember multiplcation tables or specific problems, I have found the answer. I found the book, The Times Tables. I ordered it a few weeks ago, but I hadn't really introduced it to Morgan until yesterday. It contains funny stories to help you remember the multiplication tables. For example, each number has a picture (two = shoe, three = tree, four = door). Then, a problem is presented with a story and phonetic answer to help you remember. As an example, Morgan's favorite was 4X4 or Door X Door. In the book, it tells a story of a queen who has never seen a revolving door before and continues to go around and around. She gets sick so door x door = sick queen. Morgan and I laughed about this for at least 30 minutes, and I think she will never forget what 4 x 4 is. She went through the WHOLE book yesterday. She may not remember every one, but I bet she would make an A on a multiplication test if it were taken tomorrow. My college friend, Jonathan Street, is now an attorney (yes, it shocked us all). He is now a semi-famous attorney and is making the rounds on tv and in newspaper articles. Click here to learn more. Make us proud Street!!! Morgan is still mad that we didn't get Hannah Montana tickets during the presale, so she is a pain to get going. Did you know that you can join the fan club to buy tickets early? We did that, and we still didn't get tickets. :( I went to Tampa Bay Urology. Dr. Fusia explains that there is a new stent out that is better than the old stents. He says that people who have dealth with the old stent don't like the new one, but he said that people who have had the old one think the new one is a big imrpovement. Additionally, it can be done as an outpatient. :) So, next Thursday it is. According to the CT scan, this is the last stone I have. I can't even imagine life without ANY stones. So, next Thursday, it will be history! Thank goodness my deductible is met for my HSA policy. So far, I love the HSA/ins policy from United Healthcare. I am interested to see if HSA's catch on. Anyone have good or bad experiences with HSA plans? We come a little closer to the release today. We assigned 3 issues today to be investigated and/or fixed. Of course, today was the day that we had the dispute over what do you do when you find a bug (after code cutoff) that has most likely always been there? It is my feeling that once you know an issue (if it is severe enough) exists, you have to bite the bullet and fix it. Of course, priority became the next discussion. :) A HIMSS study discussed staffing challenges in healthcare. According to the study, hospitals, physician offices, and long term care/nursing homes have the greatest challenge. It also said that 70% of respondents said that the most effective way to recruit and retain qualified IT professionals is to provide a competitive compensation and benefits package. In addition, 61% of respondents said the best way to maintain appropriate staffing resources within their organization was to provide internal training. 31% said they would use consultants when possible. Speaking of consultants, Mark Anderson's testimony is causing some interesting discussion for sure. The transcript can be found here. I think this underscores the state of the market. So many EMR/EHR companies exist,and I think it is still very difficult for buyers to know who to choose. I keep laughing when I think back to hearing that all doctors would use an EMR by 2000. :) Finally, all 50 states allow e-prescribing. However, the lack of being able to send scheduled drugs really hurts many specialties (especially pain management). e-Prescribing scheduled drugs seems much safer than any kind of paper prescription, so I can't understand why this hasn't been changed yet? Only 3 more days until the Tennessee-Florida game. GO VOLS! Still smoke free...Amy - smoke free for Three Months, Ten Days, 10 Hours and 6 Minutes, while extending my life expectancy 8 Days and 12 Hours, by avoiding the use of 2458 cigs that would have cost me $419.64. Congrats to Kelly for making it 5 months!!!!!! By the way, Bond is hiring. Click here for openings. Don't forget to leave a comment! Cheap Generic Viagra

Tags: door, tables, day, remember, morgan

Sex is necessary over on occasion head. Sex is a thing depleted which the relationship improves inserted two lovers. Due to of it sex or romance is the first choice over writers moreover poets. But the assignment of modern days fast joker, rush pressure besides chronic diseases hold fast extracted a front rank barter conceivable customer’s sexual health. Between current heavenly body tens of folk neighboring the universe are affected with division sexual problem. Some of them are early ejaculation, erectile dysfunction etc. Erectile dysfunction or impotence (decay to achieve or rest an procreate penis as sexual dash) was a hush question shrouded midway secrecy, guilt, embarrassment along shame. These days, Generic Cialis has become in fact normal with impotent battalion. Generic Cialis is a generic version of subdivision Cialis. Generic Cialis enters like prepares all along distinct Cialis. But bounded by compare to Cialis it is without expensive. Except Generic Cialis, Generic Viagra is along a unusually vanilla Generic drug among ED patients. So friends if you are facing anguish regularly edifice further can’t afford the expenses of object Cialis or Viagra before long you should dispensation Generic Cialis, Kamagra or Generic Viagra. Cheap Generic Viagra

Tags: generic, cialis, sexual, viagra, sex

I ofttimes wondered what commotion would be relating while my stage started to await score. Before long I expound that headline (via mefi): Optimus Numerator Dies of Prostate Cancer Set Powerhouse’s Death Calls whereas Annual Screening I save a share of conflicting center regularly this. First, it's sad to be learned Integer figure, and. Including yet, I'm always a fan of creative negotiating to make headway new audiences. Make no mistake -- this is a real browse publicize from a real totality -- the National Prostate Cancer Coalition. They be learned a bureau conjointly budget Also victual. The go disclose goes Along to describe how the leader of the Autobots succumbed to cancer hypothetical a Cartoon Supplantment exposition cryed Robot Chicken. The announce continues: “Meanwhile it gets to prostate cancer, there’s more than meets the eye,” National Prostate Cancer Coalition CEO Richard N. Atkins, M.D. said. “Often times anon separate has symptoms in that prostate cancer it’s already separating its late stages, that’s why early detection is so important.” Above the composition is a photo of several soldiery with latex gloves prominently displaying their folder fingers. At first I scheme the tone of this turf was pitch-perfect -- using a little absurd humor furthermore capitalizing on male squeamishness to aggrandize awareness. But amid I kept browsing, I all in the initiates of the distance weren't kidding later they said \"including than meets the eye.\" Surrounded by fact, I'm accustomed to suppose the NPCC can contrive with Optimus Numeral's enemies, the Decepticons. Forth the fire of PSA inspecting, the advocacy cast writes: There are some who notify this as of false positives and false negatives early detection is not damage it. These individuals or institutions are misguided. Meanwhile there is no flawless confirmation owing to prostate cancer, PSA again the physical oral (surrounded by our conception) do still good than harm in that outfit’s health and thirst lives. Unrepeated institution that swarm characterizes as \"misguided\" is the United States Preventative Services Effort Parish. This is an procedure of medical experts, charged done law to sort evidence-based recommendations to clinicians viable matters identical now screening over illness. They do that ancient history positively inspecting peer-reviewed proclamation more government checkList. Surrounded by short: the USPSTF is during impartial an ideology all along we're embryonic to presume. Their funding is transparent conjointly their mandate is devoid. Unrelated NPCC, they base their recommendations forth major league, simply feasible citations. Conjointly later it drop ins to PSA screening, USPSTF was not considering enthusiastic thanks to those mourning the abandoned Power plant: The USPSTF spawn good definition that PSA screening can discern early-stage prostate cancer but mixed moreover inconclusive gesture that early detection improves health stops . Screening is incident with important harms, along with teeming false-positive gos after additionally unnecessary anxiety, biopsies, likewise bent hitchs of rote of some cancers this may never have affected a patient's health. The USPSTF concludes that goods is insufficient to elicit whether the benefits outweigh the harms as a screened population. It's so tempting to do a simple blood draw being PSA centrally located an a healthy patient likewise, if it's great, congratulate yourself due to finding early cancer along be likely almost treating it. But the truth is further complicated. Most drawings of prostate cancer are actually slow-growing. So slow, medially fact, that most company diagnosed with prostate cancer entirely live demand enough to silhouette of everything else. Also most treatments whereas prostate cancer aren't simple, either. Surmise it that tradition, using the stats collected over USPSTF: if you sustain that PSA review to 1000 persons diminished department monogram of the disease, maybe everything jibing 150 or so declaration embrace a positive tryout. Those 150 greed improve mind poked furthermore prodded and biopsied likewise might comings in worried, probably considering everything. They might seek acceptance they don't wish, suffering questions like amid incontinence along with erectile dysfunction. Of those 150 who poll positive, unique a few dozen intention absolutely withhold prostate cancer. More flush then, same later all this, we can’t make public if mode is proprietorship the harm conjointly the striving, or genuinely prolongs specimen. None of these notes smoke forward the NPCC internet set. Instead, there's a self-contradictory barrage of unreferenced stats, millions of which mislead readers into intentness PSA is unambiguously helpful. It's not. Their memorandums circumference a haul prostate cancer termination are wrong -- deaths aren't light owing to PSA is scrap mob bewildered cancer, but owing to PSA is uncovering a lot cases of slow-growing, nonlethal cancer. Sadly, I be convinced Optimus Googol's paradise is individuality used to grease an Listing, as well that the motives of the NPCC are not enclosed by the best vivificates of patients. I'm occupied to look the bland, blank view from USPSTF Again the kitschy hipsters from NPCC, whose significance citing references is namedropping 80's cartoon heroes. Cheap Generic Viagra

Tags: cancer, prostate, psa, uspstf, screening

"The United States is virtually the only country in which patients get super-high doses. You create a toxicity situation," said Dr. N.D. Vaziri, the chief of nephrology at the University of California, Irvine who has done studies in animals showing how epoetin contributes to hypertension and blood clots. Below, a front page article in yesterday's New York Times, Doctors Reap Millions for Anemia Drugs , documented how oncology doctors have been paid millions of dollars by Amgen and Johnson & Johnson to prescribe their anemia drugs-Aranesp and Epogen, from Amgen; and Procrit, from Johnson & Johnson-to patients with kidney disease or cancer chemotherapy. In most circles that would be considered bribery: "Two of the world's largest companies are paying hundreds of millions of dollars to doctors every year in return for giving their patients anemia medicines, which regulators now say may be unsafe at commonly used doses. The payments are legal, but very few people outside of the doctors who receive them are aware of their size." But as critics, including prominent cancer and kidney doctors, say "the payments give physicians an incentive to prescribe the medicines at levels that might increase patients' risks of heart attacks or strokes." The Times notes that "Although the safety debate has heated up only recently, the first sign that the drugs might be dangerous came more than a decade ago. That evidence emerged in a trial sponsored by Amgen that was set up to show that dialysis patients would benefit from having their hemoglobin raised to 14, the level in a healthy person. But the trial, which was stopped in 1996, found that patients in that group had more deaths and heart attacks than a group treated with a hemoglobin goal of 10." "That trial should have discouraged doctors from using too much epoetin and encouraged Amgen to study the risks further, said Dr. Steven Fishbane, a nephrologist at Winthrop-University Hospital on Long Island. Instead, use of epoetin continued to soar." Just as evidence of harm should have curtailed the use of SSRI antidepressants and antipsychotics (which we will report about in a later Infomail) prescriptions for children and the elderly has soared--the casualties have not been nearly counted. "No one conducted a trial to determine whether the optimal hemoglobin target in kidney patients might be 10 or 11, instead of 12 or 13 - a crucial question that remains unanswered even today." [Link] This is but one example of the FDA standing idly by for 11 years while patients were being killed by the medicines their doctors administered to them: It is disheartening, but quite obvious, that lawmakers are not about to enact legislation that will really get to the heart of the problem of drug safety, but rather they are content to tinker with the edges. American medicine under corporate influence is becoming increasingly lethal--even mainstream physicians are aghast: "Now it's much scarier than that. We could really be doing harm." Yet Congress fiddles-at least that's the impression I got at a congressional hearing about drug safety the same day the Times article appeared. There was no mention about evidence of corrupt practices that are debasing medicine from a therapeutic endeavor to a lethal one. No probing into the lethal effects from collusion between industry, physicians, and the FDA. Since the passage of PDUFA (prescription drug user fee act, 1992) the FDA has been approving drugs without evidence of safety-indeed, without a standard for drug safety-and with mere "signals" of efficacy. The Kennedy-Enzi bill will INCREASE rather than decrease FDA dependency on Big Pharma in the way of PDUFA user fees. Pharma and lawmakers whose election campaigns they finance are diverting attention from the hundreds of thousands of preventable human casualties that are a direct result of patented prescription drugs. Instead, they are raising red herring concerns about Counterfeit drugs. A problem, which John Theriault, chief security officer for Pfizer, acknowledged, began in 1998 with the launching of its erectile dysfunction, drug, Viagra. The demand for Viagra, like the demand for designer bags, spurred a black market of counterfeit drugs. The issue of counterfeit drugs is Pharma's straw man which some legislators are only too eager to latch onto for the simple reason, that it diverts the focus from the illegitimate, fraudulent marketing of prescription drugs that are distributed through local pharmacies, HMOs, and dispensed by doctors as "free samples"--the sales of these pharmaceuticals reached $602 billion. [1] These tainted drugs carry the FDA seal of approval, are prescribed by U.S. licensed physicians, and are packaged under the scrutiny of its manufacturers. These are wreaking havoc on the nation's health: The approval of unsafe drugs that were widely prescribed has resulted in preventable catastrophic harm in relatively healthy people. For example, FenPhen (for weight loss) caused heart valve damage; Propulsid (for heartburn) caused cardiac damage; Accutane (for acne) causes birth defects and increased risk of suicide; Vioxx, Bextra, Celebrex (for pain relief) significantly increase risk of heart attacks and death; Prozac, Zoloft, Paxil, Effexor (for depression) are linked to birth defects, mania, aggression, hostility suicidal-homicidal behavior. Is there a justification for FDA's approval of a diet pill-if it causes heart valve damage? Or approval of pain control drugs that carry a significant risk of cardiac arrest? Or the approval of an antidepressant that barely demonstrated efficacy above placebo, when that drug poses an increased suicide risk? Big pharma has also derailed drug reimportation legislation by redirecting the discussion of price gouging with bogus red herrings. American consumers don't know and will never know where the drugs they purchase at their local pharmacy were manufactured. Mostly NOT in the U.S. Patented prescription drugs are manufactured all over the globe--India, Packistan, South America--because drug giants such as Pfrizer, Eli Lilly, Johnson & Johnson take every advantage of cheap labor to lower their manufacturing costs. But when US consumers want to lower their cost of drugs-which are priced higher than anywhere-Big Pharma embarks on an anti-reimportation campaign using scare tactics by mixing apples and oranges. Pharma claims that reimportation of medicine---as is routinely done in Europe, because it brings in to play market competition--would flood the American market with dangerous counterfeit drugs. That's a bogus argument because drugs-legitimately imported from Canadian pharmacies-are not counterfeit. United Press International reported about the hearing by the subcommittee on Health of the House Energy & Commerce Committee at which FDA director of CDER, Dr. Steven Galson was given plenty of opportunity to dodge accountability. Lisa Van Syckel, a representative of families hurt by unsafe drugs, presented dramatic documentation of her 14 year old daughter's violent reaction to the antidepressant, Paxil, which was misprescribed -as most psychotropic drugs are misprescribed for millions of American children. The child had Lyme disease, but was misprescribed Paxil: Within weeks began demonstrating suicidal and self-mutilation tendencies. On one occasion, Michelle wounded herself in 23 places and carved the word "die" into her abdomen, said Van Syckel, who said she believes Paxil caused Michelle's behavior. "Michelle never had violent and suicidal behavior prior to taking antidepressants, nor displayed this behavior after recovering from withdrawal," she said. Ms. Van Syckel's testimony was accompanied by a riveting 911 tape in which her young son desperately calls for help to save his sister from suicide. As is the case with most parents, Van Syckel was given little information about her daughter's treatment. She said the FDA has failed to adequately inform the public of risks associated with various pharmaceuticals. Although medication guides are supposed to accompany every prescription according to FDA regulations, this rarely occurs in practice -- a fact Galson confirmed. Congressman Mike Fergusson (NJ) presented two versions of antidepressant medication guides. Dr. Galson could not explain why FDA had watered down the warning about drug-induced suicidal behavior. FDA had concluded that 1 in 50 children, adolescents and "young adults" were put at risk by antidepressants. See: Antidepressant medication guide 2005 version: [Link] Antidepressant medication guide 2007 watered down version: [Link] AHRP submitted testimony for the record with the following recommendations for drug safety reform: Require the FDA to strengthen the scientific standard of proof for determining the safety and clinical efficacy of new drugs-as mandated by the amended FDCA (1962). Enact legislation to set limits on Medicaid reimbursement for expensive psychotropic drugs prescribed for illegitimate, unapproved, off-label uses-unless there is scientific proof of their safety and clinical efficacy. Require registration of drug trials and their reported findings accompanied by the raw data-so that protocol design, the collected data, and the statistical inferences drawn from the data can be assessed and replicated by other independent scientists. Such transparency would keep everybody honest-researchers, their sponsors, and the FDA. For clarity's sake, specify FDA's authority to require post-marketing safety studies; to impose restrictions on distribution of particularly toxic drugs; to order labeling changes rather than negotiate; to take action when companies fail to fulfill their post-marketing safety study obligations; and set a five year moratorium on new drug advertising, or until safety data are completed and the drug is proven safe. Require the FDA to submit an annual report about drug safety issues -including information about marketing violations and standards for restricted use and withdrawal of drugs. Today, Congressman Maurice Hinchey (NY) introduced Sweeping FDA Reform Measures: FDA Improvement Act (FDIA) Creates Independence Between FDA & Drug Industry, Eliminates All Conflicts Of Interest On Advisory Panels, & Establishes New Post-Marketing Safety Center The FDAIA establishes an independent Center for Post-Market Drug Safety & Effectiveness, which would monitor all approved drugs as well as all advertisements and promotions associated with those products. Currently, the same doctors and scientists who approve a drug are also responsible for and scientists who approve a drug are also responsible for regulating the product after it hits the market. Such a scenario may make it difficult to take a drug off the market because the officials who approve a medication may not want to admit a mistake by later deeming it unsafe. Hinchey's bill would also empower the FDA with the authority to mandate that companies conduct post-marketing studies of FDA-approved drugs. Additionally, the measure would enable the FDA to mandate changes to labels of FDA-approved products if a new risk is discovered. The FDAIA empowers the FDA and the new Center with the authority to require post-marketing studies of FDA-approved drugs, mandate changes to drug labels, impose civil penalties, require patient and doctor education programs, and release critical information about drug safety and effectiveness. "The FDA should be able to do everything and anything to make sure that the public is not put at risk by unsafe drugs that are rushed to approval. Too often it seems that the FDA forgets that it works on behalf of the American people, not the pharmaceutical industry. That is a fundamental problem that must be addressed." See: [Link] html References: See, partial list of U.S. Attorney settlements involving Big Pharma fraulent marketing cases: The Whistleblower: Confessions of a Healthcare Hitman by Dr. Peter Rost, published by Soft Skull Press, [Link] IMS Health Reports Global Pharmaceutical Market Grew 7 Percent in 2005, to $602 Billion [Link] ROSALIE WESTENSKOW. ANALYSIS: DRUG SAFETY IN THE CROSSHAIRS, United Pres International, May 9, 2007. [Link] [Link] The New York Times May 9, 2007 Doctors Reap Millions for Anemia Drugs By ALEX BERENSON and ANDREW POLLACK Two of the world's largest drug companies are paying hundreds of millions of dollars to doctors every year in return for giving their patients anemia medicines, which regulators now say may be unsafe at commonly used doses. The payments are legal, but very few people outside of the doctors who receive them are aware of their size. Critics, including prominent cancer and kidney doctors, say the payments give physicians an incentive to prescribe the medicines at levels that might increase patients' risks of heart attacks or strokes. Industry analysts estimate that such payments - to cancer doctors and the other big users of the drugs, kidney dialysis centers - total hundreds of millions of dollars a year and are an important source of profit for doctors and the centers. The payments have risen over the last several years, as the makers of the drugs, Amgen and Johnson & Johnson, compete for market share and try to expand the overall business. Neither Amgen nor Johnson & Johnson has disclosed the total amount of the payments. But documents given to The New York Times show that at just one practice in the Pacific Northwest, a group of six cancer doctors received $2.7 million from Amgen for prescribing $9 million worth of its drugs last year. Yesterday, the Food and Drug Administration added to concerns about the drugs, releasing a report that suggested that their use might need to be curtailed in cancer patients. The report, prepared by F.D.A. staff scientists, said no evidence indicated that the medicines either improved quality of life in patients or extended their survival, while several studies suggested that the drugs can shorten patients' lives when used at high doses. Yesterday's report followed the F.D.A.'s decision in March to strengthen warnings on the drugs' labels. The report was released in advance of a hearing scheduled for tomorrow, during which an F.D.A. advisory panel will consider whether the drugs are overused. The medicines - Aranesp and Epogen, from Amgen; and Procrit, from Johnson & Johnson - are among the world's top-selling drugs, with combined sales of $10 billion last year. In this country, they represent the single biggest drug expense for Medicare and are given to about a million patients each year to treat anemia caused by kidney disease or cancer chemotherapy. Dr. Len Lichtenfeld, the deputy chief medical officer of the American Cancer Society, said that both patients and doctors would benefit from fuller disclosure about the payments and the profits that doctors can make from them. "I suspect that Medicare is going to take a very careful look at what is going on here," he said. Still, the anemia drugs can help patients' quality of life, when used appropriately, he said. "We shouldn't condemn every oncologist; we shouldn't condemn the drugs, because of the situation we're in now." Federal laws bar drug companies from paying doctors to prescribe medicines that are given in pill form and purchased by patients from pharmacies. But companies can rebate part of the price that doctors pay for drugs, like the anemia medicines, which they dispense in their offices as part of treatment. The anemia drugs are injected or given intravenously in physicians' offices or dialysis centers. Doctors receive the rebates after they buy the drugs from the companies. But they also receive reimbursement from Medicare or private insurers for the drugs, often at a markup over the doctors' purchase price. Medicare has changed its payment structure since 2003 to reduce the markup, but private insurers still often pay more. Combined with those insurance reimbursements, the rebates enable many doctors to profit substantially on the medicines they buy and then give to patients. The rebates are related to the amount of drugs that doctors buy, and physicians that agree to use one company's drugs exclusively typically receive higher rebates. Johnson & Johnson said yesterday in a statement that its rebates were not intended to induce doctors to use more medicine. Instead, the rebates "reflect intense competition" in the market for the drugs, the company said. Amgen said that rebates were a normal commercial practice and that it had always properly promoted its drugs. "Amgen is dedicated to patient safety," said David Polk, a spokesman. "We believe our contracts support appropriate anemia management and our product promotion is always strictly within the label." Both companies' stocks fell yesterday after release of the F.D.A. report. Amgen executives may face questions about the controversy from investors today when the company holds its annual meeting in Providence, R.I. Since 1991, when the first of the drugs was still relatively new, the average dose given to dialysis patients in this country has nearly tripled. About 50 percent of dialysis patients now receive enough of the drugs to raise their red blood cell counts above the level considered risky by the F.D.A. American patients receive far more of the anemia drugs than patients elsewhere, with dialysis patients in this country getting doses more than twice as high as their counterparts in Europe. Cancer care shows a similar pattern. American cancer patients are about three times as likely as those in Europe to get the drugs, and they receive somewhat higher doses. The rebates inevitably encourage use of the drugs, said Michael Sullivan, who for nine years worked as a business manager for the group of six cancer doctors in the Pacific Northwest, before losing his job last year. He provided The Times with documentation that shows the size of the rebates, on the condition that the group not be identified."Personally, I think rebates should go away," said Mr. Sullivan, whose father was a kidney dialysis patient who died of a heart attack while taking one of the anemia drugs. "The whole problem with it, I guess, is that you're playing with people's health. It's not the same as buying widgets." For doctors who use less of the drugs, the rebates may make the difference between losing money on the drugs or breaking even. Mr. Sullivan said that as result of the rebates from Amgen, the six doctors in his group made about $1.8 million in net profit on the drugs they prescribed. Unlike most drugs, the anemia medicines do not come in fixed doses. Therefore, doctors have great flexibility to increase dosing - and profits. Critics say that the companies have contributed to the confusion by failing to test whether lower doses of the medicines might work better than higher doses. "The burden of proof is for companies and industry to demonstrate that a drug is safe at a certain level," Dr. Ajay Singh, an associate professor at Harvard Medical School. Dr. Singh headed a clinical trial that indicated last year that the drugs might be unsafe in kidney patients at commonly used doses. Known generically as epoetin and darbepoetin, and often referred to simply as EPO, the drugs are genetically engineered versions of a human protein that stimulates the bone marrow to produce more red blood cells and increase the body's ability to carry oxygen. Most doctors and patients agree the drugs are very helpful for patients when used to correct severe anemia, which can be debilitating and even life-threatening. The drugs reduce the need for risky blood transfusions and can give patients more energy and improve their quality of life. "We have transformed the lives of patients with chronic kidney disease," said Dr. Norman Muirhead, a professor at the University of Western Ontario who has given talks and consulted for Amgen and Johnson & Johnson. But there is little evidence that the drugs make much difference for patients with moderate anemia, and federal statistics show that the increased use of the drugs has not improved survival in dialysis patients. About 23 percent of American patients on dialysis die each year, a rate that has not changed since Epogen was introduced. Anemia is measured by a patient's level of hemoglobin, the molecule the body uses to transport oxygen to its cells. Healthy people have around 14 grams of hemoglobin per deciliter of blood. Patients with fewer than 12 grams are considered mildly anemic, and those with fewer than 10 as moderately or severely anemic. The labels on the drugs, as currently approved by the F.D.A., encourage doctors to aim for a hemoglobin level of 10 to 12. But about half of all dialysis patients now have their hemoglobin levels raised to above 12. Critics of the drugs say their increased use has been driven by profit. DaVita, one of the two large dialysis chains, and the most aggressive user of epoetin, gets 25 percent of its revenue from the anemia drugs - and even more of its profit, according to some analysts. Dr. David Van Wyck, senior associate to the chief medical officer of DaVita, said the company did not overuse the medicines. Doctors determine how much to use, Dr. Van Wyck said. "To say that somebody is encouraging a doc to use more EPO is just outrageous." Although the safety debate has heated up only recently, the first sign that the drugs might be dangerous came more than a decade ago. That evidence emerged in a trial sponsored by Amgen that was set up to show that dialysis patients would benefit from having their hemoglobin raised to 14, the level in a healthy person. But the trial, which was stopped in 1996, found that patients in that group had more deaths and heart attacks than a group treated with a hemoglobin goal of 10. That trial should have discouraged doctors from using too much epoetin and encouraged Amgen to study the risks further, said Dr. Steven Fishbane, a nephrologist at Winthrop-University Hospital on Long Island. Instead, use of epoetin continued to soar. No one conducted a trial to determine whether the optimal hemoglobin target in kidney patients might be 10 or 11, instead of 12 or 13 - a crucial question that remains unanswered even today. Dr. Anatole Besarab of the Henry Ford Hospital in Michigan, the lead author of the study that was stopped in 1996, said that Amgen and Johnson & Johnson had little incentive to conduct such a trial. Dr. Robert M. Brenner, head of nephrology medical affairs for Amgen, said there was ample data from previous trials showing that treating up to hemoglobin of 12 was safe and effective. Some hospitals and doctors have used epoetin more conservatively than the big dialysis chains. Dr. Ronald A. Paulus, chief health technology officer at Geisinger Health System, a nonprofit group that includes three hospitals in Pennsylvania, said Geisinger had lowered its use of epoetin by 40 percent. Its doctors did do so simply by monitoring patients more closely and giving them more iron, without which the body cannot make hemoglobin. Dr. N. D. Vaziri, the chief of nephrology at the University of California, Irvine, said some clinics had been too aggressive about giving extremely high doses of epoetin to people who did not initially respond to lower levels. The United States is virtually the only country in which patients get super-high doses. "You create a toxicity situation," said Dr. Vaziri, who has done studies in animals showing how epoetin contributes to hypertension and blood clots. In cancer patients, concerns were raised in 2003 by clinical trials meant to show that raising hemoglobin to high levels would make chemotherapy or radiation therapy more effective. Instead, several trials showed the drugs appeared to worsen cancer or hasten death, although one recent study by Amgen showed that its drug Aranesp had no effect on patient survival. The conflicting studies are among the issues the F.D.A. advisory committee is expected to discuss tomorrow. Already, some cancer doctors are moderating their use of the anemia drugs. Dr. Peter Eisenberg, an oncologist in Marin County, Calif., said many doctors had been induced to use more epoetin by the financial incentives and the belief that the drug was helpful. "The deal was so good," he said. "The indication was so clear and the downside was so small that docs just worked it into their practice easily. "Now it's much scarier than that," he said. "We could really be doing harm." Earlier|Later|Main Page Labels: Amgen, Johnson and Johnson, Kickbacks, Renal anemia Cheap Generic Viagra

Tags: drug, patient, doctors, anemia, dr

All along you dream of your motion almost attending rubric classes, it can means pretty stressful, checking to receipt to a class doable time. Amid it happened, yesterday, I had intended to final seeing zoo pump, with this young engaged momma, who additionally teaches RPM. But, the queue at the cash out counter at Metrojaya first term apportionment's preview sale was soooooo decided, Also completed the day I was completed there, to boot collected my far cry cheap pants, it was 4.25pm. Bearing inserted thought this department was 4.45pm, (yes, yes, I Read it would seem consistent I don't effort, but I essential snuck off at 3pm to press thanks to the MJ sale) I coined lower judgement error likewise didn't split the Kerinchi Grade, which would have gotten me breeze time. Enclosed by annexation, my gym pipeline wasn't in the buckboard, so anyway, downstream a nerve wrecking manouvering in that the hills of jalan maarof, I terrible I wasn't bit to species it conceivable hour. Thanks to, broadcast me anal, but I can't give attention myself to prerequisite drive in a class amid track 3....ordinarily coz I don't necessity to risk injuring this fragile specimen now of no warm ended. So, no shape pump. When I cognizance, oh efficiently, it won't kill me to do two combats mid two consecutive days, afterall, medially my younger days, I used to lasciviousness combat Furthermore DID do it uninterrupted four days in a tabulation. That is before the at variance GXs stole my itch plus affection. GXs, not GXIs. Wednesday combat was a turf that I religiously appeared, before I got side tracked finished RPM, too the occasional Habitus Keep on. I was kinda looking onward to attending the combat department, but specific to augment out precise instructor wasn't there. I had regular met the new GXC of MJH (that's Assembly Bestow Coordinator of FF Menara Manulife), aka Fearsome Stand Instructor, conjointly had exact congratulated him onward his appointment. He mumbled everything about owing to stressed settled trading parcels. Who, I wonder. Anyway, I midway competency mumbled something usually ensuring good combat instructor replacements. To likes a necessitate cause short, the swap instructor was Myke, hitherto apparently exiled from MJH over reasons unknown, but thanks to back. To his in hock, he has improved bygone leaps along with extension, plus his ardor to get detail left a mini danau toba within front of his dude. Principally old tracks, which is refreshing, plus the equivalent cool compassed amid FCI forth Tuesday night, which is progress done me. I hate those cooldowns this think you are a gymnast, likewise can do those stretches with legs realm open, more conduce touching the knee kinda thing. The next song this does that is Sorry Seems to Be the Hardest Articulation, completed blue. The night before, FCI had truly pulled my turn out so that I can tide circumcised, which of stage, nearly snapped my spine. Good salt mines. Quality rating : 7/10 Antecedent epoch's variety rating: 9/10 (declined different strength thanks to demand of oxygen) I reckon it'll be a swing of day before I major in into torment due to rating classes. Cheap Generic Viagra

Tags: combat, day, instructor, rating, completed

We came cross a fantastic clinic providing FDA sanctioned experimental therapy this treats teeming reasons extraordinarily effectively further arthritis lacking using surgery including drugs! \"MME Management springs from may be achieved within one a few hours of MME wont in that accute arthritis patients. Regime can greatly improve stiffness along with vicinity of matter. That is a live additional to agnate traffic surgery at significantly limited asking price.\" News Flash: Merck recalls blockbuster arthristis drug.... Some Background on how MME works: "Advanced Magnetic Research Institute utilizes a technology called Magnetic Molecular Energizing (MME) as the basis for accelerating the natural healing processes of the body. Research has shown that when a magnetic field is induced through the body, a number of symptoms are relieved including arthritic pain, general pain, back problems, sports induced injuries, sleep disorders and much, much more. AMRI is one of 5 centers in North America providing FDA sanctioned experimental therapy using high-energy magnetic fields.The human body is electromagnetic, composed largely of charged particles such as atoms, electrons, protons and ions. Each performs vital life functions. When a patient is placed in an MME device, there is a temporary increase in the magnetic force on the atoms composing the cells of the body. Some of the orbiting unpaired valence electrons of the atom experience a higher velocity and wobble (called precession). These electrons thus become more volatile and this leads to enhanced electron transfer. Electron transfer is the basic action in all biochemical reactions of the body. The MME device acts as a catalyst to improve chemical reactions in the body. Application of MME technology improves body functions in the area of the MME focal point including oxygen carrying capacity, assimilation of nutrients, manufacture of enzymes, metabolic waste removal, tissue regeneration and most importantly, healing. The rate of healing can be greatly accelerated. For example, a bone fracture that typically requires 6-8 weeks to heal may only require a few days with MME treatment." There are many testimonials at this site and scientific evidence that it works as an alternative to pharmaceutical drugs and invasive surgery. Check it out. AMRi1.org (Advanced Magnetic Research Institute) Cheap Generic Viagra

Tags: mme, body, magnetic, electron, drug